» Articles » PMID: 37072507

Evaluation of Perivascular Fat Attenuation with Coronary CT Angiography in Cardiac Transplantation Patients: an Imaging Biomarker Candidate for Prediction of Cardiac Mortality and Re-transplantation

Abstract

Objectives: In cardiac transplant recipients, non-invasive allograft surveillance for identifying patients at risk for graft failure remains challenging. The fat attenuation index (FAI) of the perivascular adipose tissue in coronary computed tomography angiography (CCTA) predicts outcomes in coronary artery disease in non-transplanted hearts; however, it has not been evaluated in cardiac transplant patients.

Methods: We followed 39 cardiac transplant patients with two or more CCTAs obtained between 2010 and 2021. We performed FAI measurements around the proximal 4 cm segments of the left anterior descending (LAD), right coronary artery (RCA), and left circumflex artery (LCx) using a previously validated methodology. The FAI was analyzed at a threshold of - 30 to - 190 Hounsfield units.

Results: FAI measurements were completed in 113 CCTAs, obtained on two same-vendor CT models. Within each CCTA, the FAI values between coronary vessels were strongly correlated (RCA and LAD R = 0.67 (p < 0.0001), RCA and LCx R = 0.58 (p < 0.0001), LAD and LCx R = 0.67 (p < 0.0001)). The FAIs of each coronary vessel between the patient's first and last CCTA completed at 120 kV were also correlated (RCA R = 0.73 (p < 0.0001), LAD R = 0.81 (p < 0.0001), LCx R = 0.55 (p = 0.0069). Finally, a high mean FAI value of all three coronary vessels at baseline (mean ≥  - 71 HU) was predictive of cardiac mortality or re-transplantation, however, not predictive of all cause-mortality.

Conclusion: High baseline FAI values may identify a higher-risk cardiac transplant population; thus, FAI may support the implementation of CCTA in post-transplant surveillance.

Key Point: • Perivascular fat attenuation measured with coronary CT is feasible in cardiac transplant patients and may predict cardiac mortality or need for re-transplantation.

Citing Articles

Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESC.

Caobelli F, Dweck M, Albano D, Gheysens O, Georgoulias P, Nekolla S Eur J Nucl Med Mol Imaging. 2024; 52(3):1095-1118.

PMID: 39436435 PMC: 11754344. DOI: 10.1007/s00259-024-06946-w.


The pericoronary adipose tissue attenuation in CT strongly depends on kernels and iterative reconstructions.

Lisi C, Klambauer K, Moser L, Mergen V, Manka R, Flohr T Eur Radiol. 2024; .

PMID: 39424654 DOI: 10.1007/s00330-024-11132-5.


Revisiting Biomarkers of Cardiac Allograft Vasculopathy: Addressing the Achilles Heel of Heart Transplantation.

OHara P, Gorrai A, Farr M, Peltz M, Beaini H, Moayedi Y Curr Heart Fail Rep. 2024; 21(6):580-590.

PMID: 39414739 DOI: 10.1007/s11897-024-00685-7.


The Association of Coronary Fat Attenuation Index Quantified by Automated Software on Coronary Computed Tomography Angiography with Adverse Events in Patients with Less than Moderate Coronary Artery Stenosis.

Zhang W, Li P, Chen X, He L, Zhang Q, Yu J Diagnostics (Basel). 2023; 13(13).

PMID: 37443530 PMC: 10340221. DOI: 10.3390/diagnostics13132136.

References
1.
Lund L, Edwards L, Kucheryavaya A, Benden C, Christie J, Dipchand A . The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. J Heart Lung Transplant. 2014; 33(10):996-1008. DOI: 10.1016/j.healun.2014.08.003. View

2.
Mitchell R, Libby P . Vascular remodeling in transplant vasculopathy. Circ Res. 2007; 100(7):967-78. DOI: 10.1161/01.RES.0000261982.76892.09. View

3.
Schmauss D, Weis M . Cardiac allograft vasculopathy: recent developments. Circulation. 2008; 117(16):2131-41. DOI: 10.1161/CIRCULATIONAHA.107.711911. View

4.
Costanzo M, Dipchand A, Starling R, Anderson A, Chan M, Desai S . The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010; 29(8):914-56. DOI: 10.1016/j.healun.2010.05.034. View

5.
Mehra M, Crespo-Leiro M, Dipchand A, Ensminger S, Hiemann N, Kobashigawa J . International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010; 29(7):717-27. DOI: 10.1016/j.healun.2010.05.017. View